Skip to main content
Clinical Trials/NCT07656857
NCT07656857RecruitingNot Applicable

Precision Resection of the Epileptogenic Zone Using Intraoperative Submillimeter Micro-Electrocorticography (Epi-PRECISE): A Single-Arm Trial With an External Historical Control Cohort

Beijing Tiantan Hospital1 site in 1 country85 target enrollmentStarted: September 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
85
Locations
1
Primary Endpoint
Seizure Freedom Rate at 6 Months After Surgery

Study Overview

Brief Summary

What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?

Detailed Description

  1. Compare the effect of intraoperative high-density flexible μECoG guidance versus no intraoperative μECoG guidance on surgical prognosis in patients with drug-resistant focal epilepsy.
  2. Explore intraoperative electrophysiological biomarkers recorded by high-density μECoG that are associated with surgical prognosis.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Masking Description

Outcome assessors will be blinded to group allocation when evaluating postoperative seizure outcomes. Due to the surgical nature of the intervention, participants, care providers, and investigators cannot be masked.

Eligibility Criteria

Ages
3 Years to 60 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 3 to 60 years.
  • •Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications.
  • •Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery.
  • •Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required.
  • •Written informed consent provided by the participant or, when applicable, by a legal guardian.

Exclusion Criteria

  • •Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation.
  • •History of any previous neurosurgical craniotomy before epilepsy surgery.
  • •Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up.
  • •Contraindication to surgery.

Arms & Interventions

Intraoperative application of high-density flexible μECoG-Guided Resection

Experimental

Intervention: Using High-density Flexible microElectrocorticography for intraoperative monitoring (Device)

Outcomes

Primary Outcomes

Seizure Freedom Rate at 6 Months After Surgery

Time Frame: From surgery to 6 months postoperatively

The proportion of participants who remain free from any type of epileptic seizure during the 6-month postoperative follow-up period.

Secondary Outcomes

  • Seizure Severity Assessed by the National Hospital Seizure Severity Scale(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Developmental Function Assessed by the Griffiths Mental Development Scales(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Cognitive Function Assessed by the Wechsler Intelligence Scale for Children(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Cognitive Function Assessed by the Mini-Mental State Examination(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Quality of Life Assessed by the Quality of Life in Epilepsy Inventory-31 or the Pediatric Quality of Life Inventory Version 4.0(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Seizure Freedom Rate at 1 Year After Surgery(From surgery to 1 year postoperatively)
  • Postoperative Seizure Outcome According to ILAE Classification(6 months and 1 year postoperatively)
  • Monthly Seizure Frequency(Baseline, 6 months postoperatively, and 1 year postoperatively)
  • Postoperative Complications(Perioperative period, 6 months postoperatively, and 1 year postoperatively)
  • Surgery-Related Adverse Events(Perioperative period)
  • Serious Adverse Events(Perioperative period)

Investigators

Sponsor
Beijing Tiantan Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kai Zhang

Director of the Department of Neurosurgery, Clinical Professor

Beijing Neurosurgical Institute

Study Sites (1)

Loading locations...

Similar Trials

High-density Flexible μECoG for Epilepsy... | Clinical Trial